FDA Clears Faster Diagnostic Test for MRSA
The US Food and Drug Administration (FDA) has approved a new, faster diagnostic test based on bacterial viability and a novel technology to detect methicillin-resistant Staphylococcus aureus (MRSA) bacterial colonization, a common cause of hospital-acquired infections. The cobas vivoDx MRSA diagnostic test, from Roche Molecular Systems, may allow healthcare providers to evaluate patients for colonization with MRSA bacteria… Read More »FDA Clears Faster Diagnostic Test for MRSA